Since 1995, 11 adult patients with oxacillin-resistant Staphylococcus aureus (ORSA) meningitis have been identified at Chang Gung Memorial Hospital-Kaohsiung, in Kaohsiung, Taiwan. The 11 patients were 8 men and 3 women, aged 17-78 years. A postneurosurgical state was an underlying condition for all, and fever and disturbances in consciousness were the most common clinical manifestations. Infection with S. aureus only was found in 8 patients, and mixed infection was found in the other 3. The 8 patients with meningitis caused by S. aureus only were mainly treated with intravenous vancomycin, 2-4 g/day; 4 of these patients died. Although ORSA meningitis is uncommon among adults with culture-proven bacterial meningitis, its incidence has been increasing in recent years. The diagnosis of adult ORSA meningitis can be confirmed only with a positive culture of cerebrospinal fluid, and the choice of initial empirical antibiotics must be guided by the accumulated data concerning the relative frequency of the implicated pathogens found at each institution. Despite the high rate of mortality associated with ORSA meningitis, intravenous vancomycin therapy seems to be one of the best choices for management of this condition in adults.
Patients and Methods
During a period of 14 years (January 1986 through December 1999), 223 adult patients were identified as having culture-proven bacterial meningitis at Chang Gung Memorial Hospital-Kaohsiung in Kaohsiung, Taiwan. Of these 223 patients, 22 were identified as having S. aureus meningitis. Six of the 22 cases occurred before the end of 1994, and the other 16 occurred between 1995 and the end of 1999. The distribution of cases during the 14-year period is shown in figure 1. Of the 22 patients with S. aureus meningitis, 11 were found to have ORSA meningitis. The clinical characteristics and outcomes of therapy for these 11 patients are described in this report. The clinical characteristics of the other 11 patients, all of whom had oxacillin-susceptible S. aureus (OSSA) meningitis, were also included in this study for comparison.
A definite diagnosis of S. aureus meningitis was based on (1) isolation of S. aureus in у1 CSF cultures; (2) typical CSF findings, including a decreased glucose level, increased lactate and protein concentrations, and pleocytosis with a predominance of polymorphonuclear cells; and (3) classic clinical manifestations, including fever, disturbances in consciousness, and signs of meningeal irritation.
Antibiotic susceptibility was tested by use of the Kirby-Bauer disk-diffusion method (BBL Mueller-Hinton II agars; Becton Dickinson Microbiology Systems, Cockeysville, MD). The gram-positive susceptibility methodology of the Vitek System (bioMérieux Vitek, Hazelwood, MO), an established automated method of testing antimicrobial susceptibility that has the ability to generate MIC data, was also used to further determine the antimicrobial susceptibility of staphylococci. The MIC breakpoints were based on guidelines of the National Committee for Clinical Laboratory Standards. Susceptibility was indicated by the MIC value. In our hospital, antimicrobial MICs in CSF have been determined since 1997; therefore, the MICs of vancomycin for 4 patients are listed in this study.
Results
Basic clinical and laboratory data for the 11 patients with ORSA meningitis are listed in tables 1 and 2. These 11 patients were 8 men (mean age, 37 years; range, 17-58 years) and 3 women (mean age, 67 years; range, 53-78 range). All had nosocomially acquired S. aureus meningitis that occurred after 1994. Underlying conditions among these 11 patients included head trauma with craniotomy in 2 patients, traumatic hydrocephalus with ventriculoperitoneal shunt in 1, traumatic intra- cerebral hemorrhage (ICH) with craniotomy plus ventriculoperitoneal shunt in 3, ICH with craniotomy in 1, ICH with ventriculostomy in 1, ICH with craniotomy and ventriculoperitoneal shunt in 2, and malignant lymphoma after intrathecal chemotherapy in 1. Diabetes mellitus was found only in 1 patient. Disturbances in consciousness occurred in all 11 patients, and fever occurred in all but 1 patient. Hydrocephalus was found in 7 patients, seizure occurred in 2, and chronic epilepsy occurred as a sequela in 1. Septic shock also occurred in 1 patient. The clinical data for the 11 patients with OSSA meningitis are listed in table 3. Of these 11 patients, 7 had a spontaneous form of OSSA meningitis, and the other 4 had a postneurosurgical form. Ten of the 11 patients with OSSA meningitis had underlying conditions, including postneurosurgical states, heart diseases, diabetes mellitus, alcoholism, and injection drug use. The remaining patient had no underlying disease. Fever and disturbances in consciousness were the most common clinical manifestations among the 11 patients with OSSA meningitis. The other clinical conditions included seizure, septic shock, brain abscess, infectious endocarditis, infectious spondylitis, spinal epidural abscess, hydrocephalus, subdural empyema, and pyomyositis.
The pathogens found in these 11 patients with ORSA meningitis included S. aureus only in 8 patients and mixed pathogens in 3 patients (table 3) . The S. aureus isolates from these 11 patients demonstrated resistance to ampicillin/sulbactam, penicillin G, and oxacillin; they retained susceptibility to vancomycin only. Among the 4 patients who were tested, the MICs of various antibiotics were as follows: penicillin, у16 mg/mL; ampicillin/sulbactam, у32 mg/mL; oxacillin, у8 mg/mL; and vancomycin, 1 mg/mL. The 4 S. aureus isolates from these 4 patients also produced b-lactamase. The ranges of laboratory values were as follows: CSF glucose, 2-85 mg/dL; total protein, 62-1,473 mg/dL; lactate, 21.9-188.6 mg/dL; and WBCs, 0-5440/mm 3 . Blood cultures were done for all but 1 of these patients, and 3 of these cultures were positive. The organisms recovered from blood cultures were the same as those found in the CSF cultures. In peripheral blood studies, leukocytosis was found in 8 patients, and leukopenia was found in 1.
Before the development of ORSA meningitis, prophylactic antibiotics were given to all 11 patients. Their antimicrobial therapy involved administration of vancomycin, 1.5-4 g/day (table 2), which was given to all but 1 patient. Because of their mixed infections, 2 patients were given concomitant therapy with ceftazidime, 6 g/day. In addition to receiving vancomycin therapy, 6 patients underwent concomitant shunt revision. Patient 6 died because a fulminant clinical course of disease developed before the availability of final culture results. Of the 10 patients who received antibiotic treatment, 7 survived and NOTE. All cases were community acquired, with the exception of the nosocomial meningitis of patient 2. APPG, aqueous procaine penicillin G; BA, brain abscess; C, disturbance in consciousness; DM, diabetes mellitus; feb, fever; H, hydrocephalus; IE, infectious endocarditis; IS, infectious spondylitis; Oxa, oxacillin; RHD, rheumatic heart disease; S, status epilepticus or seizure; SE, subdural empyema; SPE, spinal epidural abscess; SS, septic shock; s/p, status post; Vm, vancomycin; VHD, valvulas heart disease; VP, ventriculoperitoneal; Ϫ, no; ϩ, yes.
a Infected shunt removed. b Therapy given until death. c Surgical drainage performed.
3 died. All 7 surviving patients had various degrees of neurological sequelae, including hemiplegia, poor mental status, and/ or chronic epilepsy.
Discussion
Although patients with methicillin-resistant S. aureus meningitis have been reported sporadically in the English-language literature since 1983 (table 4) [6] [7] [8] [9] , there are no reported data concerning the incidence of ORSA meningitis in cases of adult bacterial meningitis. However, this study shows its increasing incidence in recent years. All 11 patients studied had postneurosurgical states as an underlying condition for the development of ORSA meningitis, a finding consistent with the results of other reports [6] [7] [8] [9] . Although severe underlying disorders were common in the 11 patients with OSSA meningitis, they were rare in the 11 patients with ORSA meningitis. Whereas 10 of the 11 patients with OSSA meningitis had community-acquired infections, all 11 of the patients with ORSA meningitis had nosocomial infections. Therefore, concurrent nosocomial infection with a postneurosurgical state was an important predisposing condition indicating the possible occurrence of adult ORSA meningitis.
In our study, the clinical manifestations found in the patients with ORSA meningitis were not as protean as those found in the patients with OSSA meningitis. Fever and disturbances in consciousness were the most consistent and most often shared clinical manifestations found among the 11 patients with ORSA meningitis. These clinical manifestations were not unique and were similar to those in other patients with adult bacterial meningitis. In fact, most postneurosurgical patients are expected to have varying degrees of disturbances in consciousness, and because many will have signs of meningeal irritation, meningitis may be indistinguishable from the usual postneurosurgical course, especially if only the level of consciousness is considered. Therefore, if fever and/or a delayed recovery from the usual postneurosurgical depressed level of consciousness is noted, then the patient should be evaluated for meningitis, with consideration of the fact that the diagnosis of ORSA meningitis can be established only by CSF culture.
Several mechanisms are implicated in the development of resistance of S. aureus to penicillinase-resistant penicillin (methicillin or oxacillin). These possible mechanisms include the production of b-lactamase; genetically mediated factors, such as overproduction of penicillin-binding proteins; and alteration in the affinity of the penicillin-binding proteins for the antimicrobials [6, 10] . Regardless of the actual mechanism of resistance, previous antibiotic therapy, which most of our patients with ORSA meningitis received, is one of the most important risk factors indicating the possible emergence of ORSA [11] . In addition to oxacillin, several ORSA strains are also resistant to many antibiotics, including other b-lactam antibiotics, macrolides, and lincosamides, although they are usually highly susceptible only to vancomycin, teicoplanin, and coumermycin [6] [7] [8] [9] .
The number of clinical studies of vancomycin for the treatment of ORSA meningitis has been limited. Vancomycin usually does not significantly penetrate the CSF in the absence of inflamed meninges, but when meningitis develops, the penetration can be enhanced to a moderate degree [12] . Although our S. aureus isolates were identified as being resistant to oxacillin and b-lactam antibiotics, they were mostly highly susceptible only to vancomycin. Several different therapeutic regimens, including iv plus intrathecal vancomycin therapy, nafcillin plus rifampicin, and vancomycin plus rifampicin, have been used in the treatment of meningitis caused by S. aureus with resistance to penicillinase-resistant penicillin (methicillin or oxacillin) [13] [14] [15] .
The exact contribution of vancomycin in the treatment of S. aureus meningitis with mixed pathogens is difficult to evaluate, as was the situation in 3 of our patients. Nevertheless, 4 of the 8 patients who had ORSA meningitis only survived after therapy with iv vancomycin, 2-4 g/day. The mortality rate was 50% (4 of 8 patients), a figure higher than the reported mortality rate associated with acute bacterial meningitis caused by a single pathogen [16, 17] and higher than the mortality rate for our patients with OSSA meningitis (1 [9%] of 11). However, our patient numbers are too low to make any definite conclusions about this unusually high mortality rate.
In conclusion, there has been an increasing incidence of adult ORSA meningitis in recent years, and a postneurosurgical state, including that which occurs after placement of an intracranial device, is one of the most important predisposing factors for its development. Although the diagnosis of ORSA meningitis in postneurosurgical adult patients can be confirmed only by a positive CSF culture, a delay in recovery of consciousness and development of fever after neurosurgery should alert the clinicians to the possibility. Although the choice of empirical antibiotics must be guided by the relative frequency of the pathogens at each institution, iv vancomycin therapy seems to be one of the best choices for management of ORSA meningitis.
